AFEYAN NOUBAR
SEC insider (Form 3/4/5 filer). CIK 0001222012. Director at Moderna, Inc. (MRNA) and 1 other issuer. 16 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in CAMBRIDGE, MA.
Companies AFEYAN NOUBAR has filed insider reports for
- Moderna, Inc. (MRNA): Director
- Generate Biomedicines, Inc. (GENB): Director, 10% Owner
AFEYAN NOUBAR
CIK: 0001222012
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- May 21, 2026MRNA
Moderna, Inc.
ExerciseIndirect9.3K shares at avg. $19.15$177K - May 21, 2026MRNA
Moderna, Inc.
SaleIndirect9.3K shares at avg. $46.84$434K - May 6, 2026MRNA
Moderna, Inc.
AwardDirectStock Option (Right to Buy)
12.9K shares- - Mar 2, 2026GENB
Generate Biomedicines, Inc.
ConversionIndirect12.7M shares- - Mar 2, 2026GENB
Generate Biomedicines, Inc.
ConversionIndirect2.8M shares- - Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseIndirect1.6M shares at avg. $16.00$25.0M - Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseIndirect1.6M shares at avg. $16.00$25.0M - Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseIndirect1.6M shares at avg. $16.00$25.0M - Mar 2, 2026GENB
Generate Biomedicines, Inc.
ConversionIndirect987.5K shares- - Mar 2, 2026GENB
Generate Biomedicines, Inc.
ConversionIndirect13.7M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  MRNA Moderna, Inc. | Exercise | 9,263 | $19.15 | $177,386 | Indirect |
| May 21, 2026 | MRNA Moderna, Inc. | Sale | 9,263 | $46.84 | $433,879 | Indirect |
| May 6, 2026 | MRNA Moderna, Inc. | Award Stock Option (Right to Buy) | 12,908 | - | - | Direct |
| Mar 2, 2026 |  GENB Generate Biomedicines, Inc. | Conversion | 12,723,940 | - | $0 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Conversion | 2,777,752 | - | $0 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Purchase | 1,562,500 | $16.00 | $25,000,000 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Purchase | 1,562,500 | $16.00 | $25,000,000 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Purchase | 1,562,500 | $16.00 | $25,000,000 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Conversion | 987,491 | - | $0 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Conversion | 13,702,224 | - | $0 | Indirect |
1-10 of 16 transactions